NervGen Pharma to Participate in Investor Conferences

NervGen Pharma Corp. announced its participation in two upcoming investor events: the H.C. Wainwright 'HCW@Home' Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference. These engagements provide the company with significant opportunities to present its latest developments and strategic outlook to the investment community. By connecting with investors and analysts, NervGen aims to enhance visibility and communicate its progress in the pharmaceutical sector. Participation in such conferences is crucial for fundraising and building investor confidence.